BioCentury
ARTICLE | Company News

Management tracks

December 5, 2015 2:09 AM UTC

Cancer and rare disease company Agios Pharmaceuticals Inc. (NASDAQ:AGIO) said COO John Higgons will resign, effective Jan. 15, 2016.

microRNA company Regulus Therapeutics Inc. (NASDAQ:RGLS) said CBO and General Counsel David Szekeres has resigned. ...